The drug aducanumab would be the first new Alzheimer’s treatment since 2003, but it is also the latest example of a controversial medication that is passionately supported by patients and advocacy groups but has been rejected by the FDA’s outside advis…
The action has been urgently sought by tobacco opponents and civil rights groups who say African Americans have been disproportionately hurt by the industry’s aggressive targeting of Black communities.
The position would be similar to one taken by Europe’s drug regulator, the European Medicines Agency, which said this week the Johnson & Johnson vaccine should carry a warning but placed no restrictions on its use.
The agencies said Tuesday that they are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the shot.